leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   807 Trials   807 Trials   14372 News 


«12...207208209210211212213214215216217...235236»
  • ||||||||||  DC-CIK / Hornetcorn Biotech
    Enrollment closed, Trial primary completion date:  Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer (clinicaltrials.gov) -  Jun 6, 2015   
    P2,  N=40, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2017 --> May 2018
  • ||||||||||  Biomarker, Enrollment open, Trial initiation date, Trial primary completion date, MSi-H Biomarker, PD(L)-1 Biomarker:  MODUL: A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) (clinicaltrials.gov) -  Jun 1, 2015   
    P2,  N=610, Recruiting, 
    Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: Jan 2015 --> Apr 2015 | Trial primary completion date: Nov 2020 --> Mar 2019
  • ||||||||||  5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg.
    New P2 trial:  HR Combined With FOLFOX4 for HCC With PVTT (clinicaltrials.gov) -  May 26, 2015   
    P2,  N=51, Active, not recruiting, 
  • ||||||||||  telisotuzumab (h224G11) / AbbVie
    Enrollment closed, Metastases:  Study of ABT-700 in Subjects With Advanced Solid Tumors (clinicaltrials.gov) -  May 22, 2015   
    P1,  N=124, Active, not recruiting, 
    N=30 --> 0 Recruiting --> Active, not recruiting
  • ||||||||||  Erbitux (cetuximab) / Eli Lilly
    Enrollment closed, Trial primary completion date:  Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study) (clinicaltrials.gov) -  Apr 30, 2015   
    P=N/A,  N=430, Active, not recruiting, 
    Trial primary completion date: Apr 2015 --> Sep 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2015 --> May 2015
  • ||||||||||  TheraSphere (yttrium 90 microspheres) / Boston Scientific
    Enrollment change, Trial primary completion date:  Phase II Trial Evaluating OS With Therasphere (clinicaltrials.gov) -  Apr 23, 2015   
    P2,  N=9, Active, not recruiting, 
    No longer recruiting --> Completed N=58 --> 9 | Trial primary completion date: May 2015 --> Dec 2015
  • ||||||||||  conatumumab (AMG 655) / Amgen
    Trial primary completion date:  Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) (clinicaltrials.gov) -  Apr 20, 2015   
    P2,  N=12, Active, not recruiting, 
    Initiation date: Jan 2005 --> Apr 2005 Trial primary completion date: Apr 2015 --> Dec 2015